Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients

Background: The efficacy of human recombinant erythropoietins (rHuEPOs) in the treatment of anemia with different etiologies is proven. Development of biosimilar rHuEPO products with lower cost and wider availability is important for the care of anemic patients. Objective: The aim of the present stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Beiraghdar, Fatemeh, Panahi, Yunes, Einollahi, Behzad, Nemati, Eghlim, Sahebkar, Amirhossein, Hassanzadeh, Arash, Khosroshahi, Hamid T., Azar, Sima A., Safa, Javid, Hashemi, Sadroddin R., Etemadi, Jalal, Marzony, Eisa T., Noshad, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605909/
https://www.ncbi.nlm.nih.gov/pubmed/26594121
http://dx.doi.org/10.1016/j.jsps.2015.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605909/
https://www.ncbi.nlm.nih.gov/pubmed/26594121
http://dx.doi.org/10.1016/j.jsps.2015.02.007

Ejemplares similares